5-MeO-DBT

5-MeO-DBT
Clinical data
Other names	5-methoxy DBT; N,N-Dibutyl-5-methoxy-1H-indole-3-ethanamine
Identifiers
	IUPAC name N-Butyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]butan-1-amine;
CAS Number	73785-42-9;
PubChem CID	53485365;
ChemSpider	30798625;
UNII	Q454YC4LIK;
CompTox Dashboard (EPA)	DTXSID10704547 ;
Chemical and physical data
Formula	C19H30N2O
Molar mass	302.462 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCN(CCCC)CCC1=CNC2=C1C=C(C=C2)OC;
	InChI InChI=1S/C19H30N2O/c1-4-6-11-21(12-7-5-2)13-10-16-15-20-19-9-8-17(22-3)14-18(16)19/h8-9,14-15,20H,4-7,10-13H2,1-3H3; Key:WVGCRISHWANOTO-UHFFFAOYSA-N;

5-MeO-DBT (5-Methoxy-N,N-dibutyltryptamine, 5-MeO-BET) is a rare substituted tryptamine derivative, which is thought to be a psychoactive substance and was identified in a designer drug sample by a forensic laboratory in Slovenia in March 2021,^[1] although only analytical studies have been conducted and no pharmacological data is available.^[2]^[3]^[4] It is nevertheless controlled under drug analogue legislation in a number of jurisdictions.

Legal status

5-MeO-DBT was made schedule I at the state level in Alabama on September 13th, 2024.^[5]

References

^ "Analytical Report. 5-MeO-DBT" (PDF). Slovenia: Nacionalni Forenzični Laboratorij. 10 March 2021.
^ Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR". Analyst. 130 (3): 330–344. Bibcode:2005Ana...130..330B. doi:10.1039/b413014f. PMID 15724162.
^ Brandt SD, Freeman S, Fleet IA, Alder JF (2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS". Analyst. 130 (9): 1258–1262. Bibcode:2005Ana...130.1258B. doi:10.1039/b504001a. PMID 16096671.
^ Brandt SD, Martins CP (2010). "Analytical methods for psychoactive N,N-dialkylated tryptamines". Trends Anal. Chem. 29 (8): 858–869. doi:10.1016/j.trac.2010.04.008.
^ "Controlled Substances List" (PDF). www.alabamapublichealth.gov.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] "Analytical Report. 5-MeO-DBT" (PDF). Slovenia: Nacionalni Forenzični Laboratorij. 10 March 2021.

[2] Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR". Analyst. 130 (3): 330–344. Bibcode:2005Ana...130..330B. doi:10.1039/b413014f. PMID 15724162.

[3] Brandt SD, Freeman S, Fleet IA, Alder JF (2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS". Analyst. 130 (9): 1258–1262. Bibcode:2005Ana...130.1258B. doi:10.1039/b504001a. PMID 16096671.

[4] Brandt SD, Martins CP (2010). "Analytical methods for psychoactive N,N-dialkylated tryptamines". Trends Anal. Chem. 29 (8): 858–869. doi:10.1016/j.trac.2010.04.008.

[5] "Controlled Substances List" (PDF). www.alabamapublichealth.gov.

[1]

[2]

[3]

[4]

[5]

5-MeO-DBT

Legal status

See also

References